|
|
|
|
Hemcheck´s Newsletter - August 2020
|
|
|
Welcome August´s newsletter from Hemcheck
We have in August been back at full speed at Hemcheck after the summer vacation period in July. We have many activities planned and ongoing, and we look forward to the autumn and the potential opportunities it can bring.
|
In this newsletter you can read about the first evaluation order we got from FIND (Foundation for Innovative New Diagnostics). It is very positive news and it will hopefully be the first step in a broader and longer-term collaboration.
|
You can also read about the next steps taken within the Bridgehead Europe program that Hemcheck is participating in, where we have selected France and the Netherlands as our focus markets.
|
Looking ahead, the main focus for our work during the autumn is to continue the commercialization efforts towards getting more paying customers. Another important area is the development of our new product for the blood gas market, which I think has good potential, and therefore will be another focus area.
|
We look forward to the fall and hope we can take the company to the next level.
|
Enjoy the reading!
Joen Averstad, CEO
|
|
|
|
|
|
Agreement with Foundation for Innovative New Diagnostics (FIND)
|
|
Hemcheck and FIND signed an agreement in July regarding delivery of reader and one-time tests (v-Test). The order is a first evaluation order.
|
It’s very positive that we have received this order and that they want to evaluate the potential in using our products, since FIND is an attractive potential global partner.
|
|
Click here to read more about the agreement.
|
|
|
|
Hemcheck has selected Medscaler and Medicen as partners within the Bridgehead program, focusing on commercial development in the Netherlands and France
Hemcheck has concluded the preparatory phase of the Bridgehead Europe program by selecting two focus markets and two local partners to support Hemcheck in the internationalization process. For the Netherlands, Hemcheck has decided to partner with Medscaler and for France, Medicen was chosen as the local partner.
|
The aim is to get a better understanding of the local markets and get introductions to relevant key opinion leaders and potential customers. The goal is to, during the program, initiate several pilots in each country in order to reach commercial agreements. The program will begin in September.
|
|
|
|
|
|
Interim report Q2 2020
We released our interim report for the second quarter of 2020 on August 31.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
